The Centers for Disease Control and Prevention (CDC) on Monday warned that a deadly fungus called Candida auris (C. auris) is spreading at an "alarming rate" in the U.S. healthcare facilities. 

“The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control,” said CDC epidemiologist Dr. Meghan Lyman, lead author of the paper, in a press release. 

Adding to the agency's concerns, the number of infections that were resistant to echinocandins, which is the antifungal medicine most commonly used to treat C. auris infections, tripled in 2021. 

The CDC classified C. auris as an "urgent antimicrobial resistance (AR) threat," meaning "it is often resistant to multiple antifungal drugs, spreads easily in healthcare facilities, and can cause severe infections with high death rates."

Between 2016, when C. auris was first reported, and 2021, there have been a total of 3,270 clinical cases reported and 7,413 screening cases. 

The agency said "poor general infection prevention and control (IPC) practices in healthcare facilities" are responsible for the spread. However, expanded efforts to detect cases is also responsible for the jump in reported cases.

Share:
More In Science
US Pregnancy Deaths Dropped in 2022, After COVID Spike
In this photo provided by Henry Danner, Omari Maynard sits with his children, Khari, left, and, Anari, holding a photo of their late mother, Shamony Gibson, at home in the Brooklyn borough of New York on April 9, 2022. Gibson passed away in 2019, two weeks after giving birth to Khari due to a pulmonary embolism. “She wasn’t being heard at all,” said Maynard, an artist who now does speaking engagements as a maternal health advocate.
Load More